CORDIS
EU research results

CORDIS

English EN
Knowledge and need assessment on pharmaceutical product in environmental waters

Knowledge and need assessment on pharmaceutical product in environmental waters

Objective

"Pharmaceuticals in the Environment" is an issue receiving growing attention. About 4000 medical compounds are being used in the drugs applied today. It is estimated that worldwide consumption of active compounds amounts to some 100 000 tons or more per year. Consequently, there is a need to highlight the most important questions and issues related to presence of pharmaceuticals in the environment. What we ought to know to understand the occurrence, the fate and the effects of pharmaceuticals in order to se t up environmental risk assessment?

By pulling together results of previous and on going EU projects and published data from both governmental sources and scientific literature, by involving manufacturers in supplying data on production and usage of pharmaceuticals, KNAPPE project will carry out the state of knowledge and put emphasis on questions deserving attention such as:
- What is the spectrum of most relevant pharmaceutical products (PP's) for the aquatic environment? Which indicators for supporting environmental managers, health authorities?
- What is the efficiency of urban and industrial sewage treatment plants over a year? What is the fate and behaviour of PP's in sewage treatment plants? If receiving waters are used for potable water supplies, does the presence of these compounds represent a potential hazard to human health?
- Could we solve some problems by environmental or cleaner technologies?
- What regulatory approaches, incentives, prevention actions can be implemented in order to lower PP's concentration in the environment? Does a European practical guidance can be developed?
- Can the impacts of PPs on the environment be reduced through the use of eco-pharmaco-stewardship approaches including the use of clean synthesis, classification and labelling, and better communication of methods of 'good practice'?
- How can we better monitor the environmental impact of a pharmaceutical once it has received a marketing authorisation?

Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

ASSOCIATION POUR LA RECHERCHE ET LE DEVELOPPEMENT DES METHODES ET PROCESSUS INDUSTRIELS - ARMINES

Address

Boulevard Saint-Michel 60
Paris

France

Administrative Contact

Benoit ROIG (Mr)

Participants (8)

Sort alphabetically

Expand all

BUNDESANSTALT FUER GEWAESSERKUNDE

Germany

BUREAU DE RECHERCHES GEOLOGIQUES ET MINIERES

France

CENTRE NATIONAL DU MACHINISME AGRICOLE, DU GENIE RURAL, DES EAUX ET DES FORETS

France

CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS

Spain

ECOLOGIC - INSTITUT FUER INTERNATIONALE UND EUROPAEISCHE UMWELTPOLITIK GGMBH

Germany

POLITECHNIKA SLASKA

Poland

UNIVERSITY OF PORTSMOUTH HIGHER EDUCATION CORPORATION

United Kingdom

UNIVERSITY OF YORK

United Kingdom

Project information

Grant agreement ID: 36864

  • Start date

    1 February 2007

  • End date

    30 September 2008

Funded under:

FP6-SUSTDEV

  • Overall budget:

    € 593 136

  • EU contribution

    € 593 136

Coordinated by:

ASSOCIATION POUR LA RECHERCHE ET LE DEVELOPPEMENT DES METHODES ET PROCESSUS INDUSTRIELS - ARMINES

France